Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand Product Offerings

Document Sample
Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand Product Offerings Powered By Docstoc
					           Dehaier Medical Systems Signs Distribution Agreement with
              HEYER Medical: A Move to Expand Product Offerings
       Reference Code: GDME0015M&A                                                                                                       Publication Date: JUN 2010

                                                                                                  2       Deal Summary
                                                                                                  On May 24, 2010, Dehaier Medical Systems Ltd (Dehaier)
       1         Table of Contents                                                                announced an exclusive distribution agreement for HEYER
                                                                                                  Medical's Cumulus ultrasonic nebulizer in China. Dehaier is
       1  Table of Contents ...............................................................1
                                                                                                  authorized to distribute all models of this product. HEYER
        1.1   List of Tables ...............................................................1
        1.2   List of Figures..............................................................1      Medical’s Cumulus is used for the treatment of respiratory tract
       2 Deal Summary....................................................................1        conditions such as asthma, bronchitis, chronic respiratory
        2.1   Rationale behind Dehaier Medical Systems Agreement                                  infections and others. It can also be used for all aspects of
              with HEYER Medical ...................................................1             respiratory treatment and air humidification. The Cumulus
        2.2   Conclusion: Dehaier Medical Systems may Explore                                     nebulizer can be used in hospitals, surgeries and home
              Additional Partnership Agreements in the near Future 3                              healthcare settings.
        2.3   Company Profiles ........................................................3
       3 Appendix ............................................................................4   Mr. Volker Muller, the General Manager of HEYER Medical
        3.1   Methodology................................................................4        (Beijing) Ltd., said, "We are very pleased that Dehaier will
        3.2   Contact Us ..................................................................5      represent HEYER products in China. Dehaier is a premier
        3.3   Disclaimer ...................................................................5
                                                                                                  medical device company that has a powerful distribution
                                                                                                  network in China. We believe this exclusive distribution
                                                                                                  agreement is an excellent business expansion opportunity for
       1.1      List of Tables                                                                    both companies."
       Table 1: Ultrasonic Nebulizers, China, Revenue ($m),                                       Mr. Ping Chen, Dehaier's Chief Executive Officer, said, "Our
                2009 – 2016 ................................................................2
                                                                                                  new partnership with HEYER Medical further supplements our
       Table 2: Dehaier Medical Systems, Company Profile, 2010 .....3
       Table 3: HEYER Medical, Company Profile, 2010 ....................3                        product line for treatment of respiratory diseases. This not only
                                                                                                  provides Dehaier with additional highly sophisticated products,
                                                                                                  but also widens the experience of our marketing and service
                                                                                                  teams. This exclusive agreement provides us with access to the
       1.2      List of Figures                                                                   market segment in China for nebulizer products. The Cumulus
       Figure 1:Strategic Fit Assessment, Dehaier Medical Systems                                 is an ideal product addition to our Homecare Medical Products
                and HEYER Medical, 2010..........................................2                segment that already includes homecare ventilators, oxygen
       Figure 2:Ultrasonic Nebulizers, China, Revenue ($m),                                       generators, sleep screening systems and our Dehaier rhinitis
                2009 – 2016 ................................................................2     hyperthermia device".
       Figure 3:GlobalData Methodology .............................................4
                                                                                                  2.1     Rationale behind Dehaier Medical Systems
                                                                                                          Agreement with HEYER Medical
                                                                                                  2.1.1    Dehaier Medical Systems to Expand its
                                                                                                           Offerings in the Anesthesia and Respiratory
                                                                                                           Devices Market in China
                                                                                                  Dehaier Medical System’s anesthesia and respiratory devices
                                                                                                  portfolio consists of anesthesia machines, ventilators, oxygen
                                                                                                  concentrators, continuous positive airway pressure devices,
                                                                                                  sleep diagnosis and screening systems, and rhin
				
DOCUMENT INFO
Shared By:
Stats:
views:72
posted:7/19/2010
language:English
pages:5
Description: Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand Product Offerings Summary GlobalData’s report, “Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand Product Offerings” provides key information and analysis on the distribution agreement between Dehaier Medical Systems and HEYER Medical. The report provides comprehensive information on deal rationale and ultrasonic nebulizers market in China. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Annualized market revenue data for ultrasonic nebulizers in China for 2009 and forecast forward to 2016. - Qualitative analysis on distribution agreement. Reasons to buy - Develop business strategies by understanding the trends and developments that are driving the medical devices market in China. - Design and develop your marketing and sales strategies. - Exploit M&A opportunities by identifying key areas of growth. - Develop market expansion strategies. - Make more informed business decisions from the insightful and in-depth analysis of the Chinese healthcare market and the factors shaping it.
BUY THIS DOCUMENT NOW PRICE: $500 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.